Pharmafile Logo
Pharmafocus logo
Advanced Search

ExonHit Therapeutics

Showing 1 posts of 1 posts found.

ExonHit-Therapeutics-Herve100

Hervé Duchesne de Lamotte, chief financial officer, ExonHit Therapeutics

December 1, 2009
Research and Development ExonHit Therapeutics, appointment, research and development

ExonHit Therapeutics appoints Hervé Duchesne de Lamotte chief financial officer.The Paris-based company develops innovative molecular diagnostic tests and therapeutics for …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026